CHICAGO, IL, USA I July 09, 2025 I MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company focused on developing targeted ...

Older patients with small cell lung cancer and significant weight loss were more likely to experience dose interruptions than ...

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

Thermo Fisher secured FDA approval for its Oncomine Dx Express Test, a rapid diagnostic for cancer gene mutations and tumor ...

Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it ...

Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had ...

Key Takeaways Steroids appear to dampen the effectiveness of immunotherapy for lung cancerPeople who got steroids before or ...

Patients on baseline steroids had lower ORR, and markedly shorter PFS survival and OS compared with those not receiving ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

Eight years after it was established partly by AstraZeneca, Dizal Pharmaceuticals has gained its first FDA approval, winning an accelerated nod for Zegfrovy (sunvozertinib) to become the only ...